Table 3.

Clinical assessments and patient-reported outcome measures

Description	Subsections	Minimum–maximum scores (worst values in bold)
A. Clinical assessments
Movement Disorders Society—Unified Parkinson's Disease Rating Scale (MDS-UPDRS)—Assessment of motor and non-motor features of Parkinson's disease65	Non-motor experience of daily living—motor experience of daily living—motor examination—motor complications	0–260
Frenchay Dysarthria Assessment, second edition (FDA-2)—Assessment of speech and voice organs59	Reflexes—Respiration—Lips—Palate—Larynx—Tongue—Intelligibility	0–104
Montreal Cognitive Assessment (MoCA)—Global assessment of cognitive functions66	Visuospatial—Naming—Memory—Attention—Verbal fluency—Abstraction—Orientation	0–30
Clinical Global Impression (CGI)—Global impression of the clinician for the symptom67	Speech	1–7
B. Patient-reported outcome measures (PROMs)
39-Item Parkinson's Disease Questionnaire (PDQ-39)—Quality of life in Parkinson's disease71	Mobility—Daily living activities—Emotional well-being—Stigma—Social support—Cognition—Communication—Body discomfort	0–156
Voice Handicap Index (VHI)72	Physical—Functional—Emotional	0–120
Dysarthria Impact Profile (DIP)—Psychosocial impact of speech deficits68	Effect of dysarthria on me—Accepting my dysarthria—How I feel others react to my speech—How dysarthria affects my communication—Dysarthria relative to other worries and concerns	48–240
Patient Global Impression (PGI)—Global impression of the patient on the dysfunction79	Speech	1–7
Beck Depression Inventory (BDI)—Global assessment of the depression profile80		0–84